Dexcom is facing scrutiny and class-action lawsuits over alleged safety and accuracy issues with its G7 monitor.

The parent of a child who wore the device to manage diabetes described failed alerts and inaccurate readings in a complaint.

DexCom, Inc. (NASDAQ:DXCM) is one of the best growth stocks to buy and hold forever. On September 22, UBS reiterated a ‘Buy’ rating on the stock and a $106 price target. The research firm reiterated ...

We came across a bearish thesis on DexCom, Inc. on Hunterbrook’s Substack. In this article, we will summarize the bulls’ thesis on DXCM. DexCom, Inc.’s share was trading at $65.41 as of October 15th.

DexCom, Inc. (NASDAQ:DXCM) is one of the Best Long Term Growth Stocks to Buy Now. On September 19, William Blair analyst Brandon Vazquez maintained their bullish stance on the company’s stock, giving ...

A powerful new AI tool called Diag2Diag is revolutionizing fusion research by filling in missing plasma data with synthetic yet highly detailed information. Developed by Princeton scientists and ...

DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include ...

“The Oura Ring boasts temperature sensors, a suite of LED lights to measure heart rate ... hit “Set up a new ring,” and follow the tutorial (it took me 30 seconds…max). Would I say that’s cheap? No.

Optical sensors are a broad class of device for detecting light intensity. This can be just a simple component for notifying when ambient light levels rise above or fall below a prescribed level, or a ...